Antidiabetics Market Size

Antidiabetics Market size is evaluated at USD 106.9 billion in 2024 and is likely to cross USD 294.1 billion by the end of 2037, registering more than 8.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of antidiabetics is assessed at USD 116.3 Billion.

The increasing cases of diabetes, the rising geriatric population, and ongoing advancements in anti-diabetic drugs are positively influencing the overall antidiabetics market growth. According to the World Health Organization (WHO), diabetes is a chronic metabolic disease that affects the eyes, heart, kidneys, and nerves over time. Type 2 diabetes is most common across the world and particularly affects adults. Type 1 diabetes also known as juvenile diabetes or insulin-dependent diabetes is chronic in nature and can be treated through insulin intakes. As per WHO estimations around 422 million people are living with diabetes globally, and about 1.5 million deaths occur yearly due to diabetes.

The rising adoption of a sedentary lifestyle, hike in obesity cases, and poor eating habits are driving the prevalence of diabetes, ultimately augmenting the sales of antidiabetic drugs. According to World Obesity Atlas 2023, more than half of the global population is likely to become obese in the next 12 years if proper treatment and support are not provided. According to the National Center for Biotechnology Information (NCBI), excess amount of body fat is one of the causes of type 2 diabetes.